Soremartec Italia S.r.l.   Report issue

For profit
Founded: ALBA Italy (1989)

Organization Overview

First Clinical Trial
2014
NCT02845622
First Marketed Drug
2004
nifedipine (procardia)
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

MARTEC USA LLC | Soremartec Italia S.r.l.

Active Ingredients

Marketed Drugs (4)

diazepam (valium)

nifedipine (procardia) (2004)

sulfamethoxazole (gantanol)

trimethoprim

Drugs in Other Trials (1)

hazelnut, unspecified (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1